Assessment of breast cancer immunohistochemistry and tumor characteristics in Nigeria

Table 3 Bi-variate correlation of clinicopathological parameters and hormonal receptors

Clinic pathologic feature	Estimators	Hormonal receptors
		ER + ve	ER - ve	PR + ve	PR - ve	Her-2 + ve	Her-2 - ve
Age	R	-0.159a	0.231b	-0.224b	-0.086	0.131a	0.202b
	P value	0.01	0.01	0.01	0.167	0.036	0.001
Grading	R	-0.144b	-0.101	0.089	0.07	0.067	0.184b
	P value	0.015	0.087	0.133	0.236	0.26	0.002
Tumour size	R	-0.144a	-0.101	0.089	0.07	0.067	0.184b
	P value	0.015	0.087	0.133	0.236	0.26	0.002
Lymph node	R	-0.051	-0.018	-0.024	0.045	-0.047	0.184b
	P value	0.401	0.761	0.689	0.455	0.438	0.002
Total		259	259	259	259	259	259

^a: Strongly significant.

^b: Significant.

ER + ve: = Estrogen receptor positive; ER - ve = Estrogen receptor negative; PR + ve =Progesterone receptor positive; PR - ve =Progesterone receptor negative, HER/2 neu + ve= Human epidermal growth factor receptor-2 positive, HER/2 neu - ve= Human epidermal growth factor receptor-2 negative.